Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03440437
Title FS118 First in Human Study in Patients With Advanced Malignancies After PD-1/PD-L1 Containing Therapy
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors F-star Delta Limited
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA


No variant requirements are available.